Table 6.
Ref. | Subjects | Artesunate regimen | Artesunate half-life (hours) |
---|---|---|---|
[29] | 10 healthy male Vietnamese adults | 200 mg once daily × 5 days | Day 1: 0.43a Day 5: 0.50a |
[30] | 12 healthy male Malaysian adults | 200 mg single dose | 0.49 |
[28] | 8 healthy male Thai adults | 300 mg AS (Guilin or Arenco formulation) | Guilin:0.53 Arenco:0.57 |
[26] | 23 healthy Malaysian adults | 200 mg AS + amodiaquine as fixed or non-fixed product | Fixed:0.63 Non-fixed:0.76 |
[34] | 86 acute uncomplicated falciparum malaria patients from Malawi and Gambia | 1, 2, or 4 mg/kg AS + chlorproguanil and dapsone once daily × 3 days | 1 mg/kg: 0.515b 2 mg/kg: 0.478b 4 mg/kg: 0.467b |
[31] | 11 male Thai adults with uncomplicated falciparum malaria | 200 mg AS once, followed by 100 mg 12 hours later, then 100 mg once daily × 4 days | Acute: 0.36a Convalescence: 0.54a |
[35] | 6 male Thai adults with uncomplicated falciparum malaria and 6 healthy male adults | 100 mg AS once | Healthy: 0.41 Patients: not determined |
[36] | 57 children (2-14 years) with uncomplicated falciparum malaria in Gabon | AS dose (mg/kg) with pyronaridine Group A:2.1(1.4-2.4) Group B:3.3(2.4 - 3.9) Group C:4.8(3.0 - 6.1) Group D: 3.8(3.0-4.3) |
Group A: 0.8 (n = 12) Group B:1.1 (n = 12) Group C:0.5 (n = 10) Group D:1.2 (n = 13) |
[37] | 40 children and adults with uncomplicated falciparum malaria in Pailin, Cambodia and 40 adults with uncomplicated falciparum malaria in Wang Pha, Thailand | At each site: Group 1: AS monotherapy: 2 mg/kg/day × 7 days Group 2: AS 4 mg/kg/day × 3 days + mefloquine |
Thailand: Group 1: 0.37a Group 2: 0.58a Cambodia: Group 1: 0.29a Group 2: 0.29a |
Value given as mean unless otherwise specified.
a. Median b. Geometric mean